| Date | Opening price | Maximum price |
|---|---|---|
| April 2025 | Open: 0.000001 | Max: 0.000001 |
| May 2025 | Open: 0.000001 | Max: 0.000001 |
| June 2025 | Open: 0.000001 | Max: 0.000001 |
| July 2025 | Open: 0.000001 | Max: 0.000001 |
Is onph a good stock?
The nanoemulsion delivery system is intended to increase the overall safety of dactinomycin, a potent cancer drug that has been previously cleared to treat cancer, including pediatric cancer, but has limited utility due to its high toxicity and narrow safety margin (“therapeutic window”).
Should you buy onph stock?
The capital outlay is projected to be significantly lower than traditional drug development programs and there is a high need for improved therapies for patients with rare cancers with the potential for Oncology Pharma to positively impact these patients worldwide.
Is onph worth investing in?
Momelotinib, for its part, appears poised to continue this rich tradition. So yes, GlaxoSmithKline does appear to be getting a worthwhile asset at a fair price. When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
Is onph a buy now?
There are mixed signals in the stock today. The Oncology Pharma Inc. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal.
Is Oncology Pharma a Good stock to buy now?
Is Oncology Pharma Inc. stock A Buy? Oncology Pharma holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Is ONPH a buy Zacks?
The VGM Score are a complementary set of indicators to use alongside the Zacks Rank....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
Is ONPH a OTC stock?
ONPH | Oncology Pharma Inc. Stock Overview (U.S.: OTC) | Barron's.
Does ONPH pay a dividend?
Dividends. ONPH does not currently pay a dividend.
Is ONPH a good investment?
If you are looking for stocks with good return, Oncology Pharma Inc stock can be a bad, high-risk 1-year investment option. Oncology Pharma Inc real time quote is equal to 1.410 USD at 2022-07-07, but your current investment may be devalued in the future.
Can you buy ONPH stock on Robinhood?
Shares of ONPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
What does Oncology Pharma do?
Oncology Pharma, Inc. is a pioneering oncology company dedicated to providing the financing and the tools to license, develop, manufacture, and commercialize therapeutics.
Is ONPH on Nasdaq?
*Today's High/Low is only updated during regular trading hours; and does not include trades occurring in pre-market or after-hours....ONPH Real-Time Quotes.Nasdaq Last Sale (NLS) Plus Volume39,995Today's High / Low*$1.53/$1.4152 Week High / LowN/A1 more row•Jul 8, 2022
Who owns Oncology Pharma?
Marcel van HeesewijkOncology Pharma Inc (OTC Pink - Current Information:ONPH) The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San Francisco, CA.
How do I buy Oncology Pharma stock?
You can buy Oncology Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Is Oncology Pharma publicly traded?
Yes, Oncology Pharma is a publicly traded company.
What did oncology pharmacy close at today?
1.4050Performance OutlookPrevious Close1.4050Day's Range1.3500 - 1.530052 Week Range1.3100 - 28.3200Volume116,752Avg. Volume61,7633 more rows
"Should I invest in Oncology Pharma stock?" "Should I trade "ONPH" stock today?"
According to our live Forecast System, Oncology Pharma Inc stock is an awesome long-term (1-year)...
What is the Oncology Pharma stock price / share price today?
The Oncology Pharma stock price is 3.570 USD today.
Will Oncology Pharma stock price grow / rise / go up?
Yes. The ONPH stock price can go up from 3.570 USD to 9.273 USD in...
Is it profitable to invest in Oncology Pharma stock?
Yes. The long-term earning potential is + 159.74 % in one year.
Will ONPH stock price fall / drop?
No. See above .
What will Oncology Pharma stock price be worth in five years (2027)?
The ONPH ("ONPH" ) future stock price will be 27.564 USD .
Will ONPH stock price crash?
According to our analysis, this will not happen.
Will Oncology Pharma stock price hit 10 USD price in a year?
Not within a year. See above .
Will Oncology Pharma stock price hit 20 USD price in a year?
Not within a year. See above .
How has Oncology Pharma's stock performed in 2022?
Oncology Pharma's stock was trading at $4.05 on January 1st, 2022. Since then, ONPH stock has decreased by 54.3% and is now trading at $1.85. View...
Who are Oncology Pharma's key executives?
Oncology Pharma's management team includes the following people: Mr. Chuck Wagner , Pres, Treasurer & Chairman Mr. George Malesek , Interim Chie...
Who are some of Oncology Pharma's key competitors?
Some companies that are related to Oncology Pharma include IronNet (IRNT) , MiX Telematics (MIXT) , Kaltura (KLTR) , Ventoux CCM Acquisition (V...
What is Oncology Pharma's stock symbol?
Oncology Pharma trades on the OTCMKTS under the ticker symbol "ONPH."
How do I buy shares of Oncology Pharma?
Shares of ONPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is Oncology Pharma's stock price today?
One share of ONPH stock can currently be purchased for approximately $1.85.
How much money does Oncology Pharma make?
Oncology Pharma (OTCMKTS:ONPH) has a market capitalization of $62.46 million.
How many employees does Oncology Pharma have?
Oncology Pharma employs 1 workers across the globe.
What is Oncology Pharma's official website?
The official website for Oncology Pharma is www.oncology-pharma.com .
Signals & Forecast
The Oncology Pharma Inc. stock holds a sell signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock.
Support, Risk & Stop-loss
On the downside, the stock finds support just below today's level from accumulated volume at $4.55 and $4.49. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Oncology Pharma Inc. finds support just below today's level at $4.55.
Is Oncology Pharma Inc. stock A Buy?
Oncology Pharma Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Oncology Pharma Inc
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc.
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Oncology Pharma Inc Stock Forecast
Is Oncology Pharma Inc Stock Undervalued? The current Oncology Pharma Inc [ ONPH] share price is $4.96. The Score for ONPH is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Oncology Pharma Inc Stock Price History
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ONPH is experiencing slight selling pressure.
Stock Predictions
Is Oncology Pharma Inc stock public? Yes, Oncology Pharma Inc is a publicly traded company.
ONPH Stock Trend
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.
About Oncology Pharma Inc
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc.
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
What is an OTC forecast?
Oncology OTC Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Oncology Pharma historical stock prices and determine the direction of Oncology Pharma's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading. Macroaxis recommends to always use this module together with analysis of Oncology Pharma historical fundamentals such as revenue growth or operating cash flow patterns.
What is the analysis of Oncology Pharma's basic risk indicators?
The analysis of Oncology Pharma's basic risk indicators is one of the essential steps in helping accuretelly forecast its future price. The process involves identifying the amount of risk involved in Oncology Pharma's investment and either accepting that risk or mitigating it.
What is market strength indicator?
Market strength indicators help investors to evaluate how Oncology Pharma otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncology Pharma shares will generate the highest return on investment. By undertsting and applying Oncology Pharma otc stock market strength indicators, traders can identify Oncology Pharma entry and exit signals to maximize returns.
Is the stock market volatile?
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Oncology Pharma's price movements, , a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Oncology Pharma's current price.
